Skip to main content
Erschienen in: Annals of Surgical Oncology 3/2007

01.03.2007

Resection of Isolated Pelvic Recurrences After Colorectal Surgery: Long-Term Results and Predictors of Improved Clinical Outcome

verfasst von: Leonard R. Henry, MD, Elin Sigurdson, MD, PhD, Eric A. Ross, PhD, John S. Lee, MD, James C. Watson, MD, Jonathan D. Cheng, MD, Gary M. Freedman, MD, Andre Konski, MD, John P. Hoffman, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Recurrence in the pelvis after resection of a rectal or rectosigmoid cancer presents a dilemma. Resection offers the only reasonable probability for cure, but at the cost of marked perioperative morbidity and potential mortality. Clinical decision making remains difficult.

Methods

Patients who underwent resection with curative intent for isolated pelvic recurrences after curative colorectal surgery from 1988 through 2003 were reviewed retrospectively. Clinical and pathological factors, salvage operations, and complications were recorded. The primary measured outcome was overall survival. Univariate and multivariate analyses were conducted to identify prognostic factors of improved outcome.

Results

Ninety patients underwent an attempt at curative resection of a pelvic recurrence; median follow-up was 31 months. Complications occurred in 53% of patients. Operative mortality occurred in 4 (4.4%) of 90 patients. Median overall survival was 38 months, and estimated 5-year survival was 40%. A total of 51 of 86 patients had known recurrences (15 local, 16 distant, 20 both). Multivariate analysis revealed that preoperative carcinoembryonic antigen level and final margin status were statistically significant predictors of outcome.

Conclusions

The resection of pelvic recurrences after colorectal surgery for cancer can be performed with low mortality and good long-term outcome; however, morbidity from such procedures is high. Low preoperative carcinoembryonic antigen and negative margin of resection predict improved survival.
Literatur
3.
Zurück zum Zitat Tepper JE, O’Connell M, Hollis D, Niedzwiecki D, Cooke E, Mayer RJ. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from intergroup study 0114. J Clin Oncol 2003; 21:3623–8CrossRef Tepper JE, O’Connell M, Hollis D, Niedzwiecki D, Cooke E, Mayer RJ. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from intergroup study 0114. J Clin Oncol 2003; 21:3623–8CrossRef
4.
Zurück zum Zitat Karanjia ND, Schache DJ, North WR, Heald RJ. “Close shave” in anterior resection. Br J Surg 1990; 77:510–2CrossRef Karanjia ND, Schache DJ, North WR, Heald RJ. “Close shave” in anterior resection. Br J Surg 1990; 77:510–2CrossRef
5.
Zurück zum Zitat Carlsson U, Lasson A, Ekelund G. Recurrence rates after curative surgery for rectal carcinoma, with special reference to their accuracy. Dis Colon Rectum 1987; 30:431–4CrossRef Carlsson U, Lasson A, Ekelund G. Recurrence rates after curative surgery for rectal carcinoma, with special reference to their accuracy. Dis Colon Rectum 1987; 30:431–4CrossRef
6.
Zurück zum Zitat Gunderson LL, Sosin H. Areas of failure found at reoperation following “curative surgery” for adenocarcinoma of the rectum. Cancer 1974; 34:1278–92CrossRef Gunderson LL, Sosin H. Areas of failure found at reoperation following “curative surgery” for adenocarcinoma of the rectum. Cancer 1974; 34:1278–92CrossRef
7.
Zurück zum Zitat Wanebo HJ, Gaker DL, Whitehill R, Morgan RF, Constable WC. Pelvic recurrence of rectal cancer. Options for curative resection. Ann Surg 1987; 205:482–95CrossRef Wanebo HJ, Gaker DL, Whitehill R, Morgan RF, Constable WC. Pelvic recurrence of rectal cancer. Options for curative resection. Ann Surg 1987; 205:482–95CrossRef
8.
Zurück zum Zitat Garcia-Aguilar J, Cromwell JW, Claudio M, Lee SH, Madoff RD, Rothenberger DA. Treatment of locally recurrent rectal cancer. Dis Colon Rectum 2001; 44:1743–8CrossRef Garcia-Aguilar J, Cromwell JW, Claudio M, Lee SH, Madoff RD, Rothenberger DA. Treatment of locally recurrent rectal cancer. Dis Colon Rectum 2001; 44:1743–8CrossRef
9.
Zurück zum Zitat Esnaola NF, Cantor ML, Johnson AT, et al. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol 2002; 20:4361–7CrossRef Esnaola NF, Cantor ML, Johnson AT, et al. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol 2002; 20:4361–7CrossRef
10.
Zurück zum Zitat Miner TJ, Jaques DP, Paty PB, Guillem JG, Wong WD. Symptom control in patients with locally recurrent rectal cancer. Ann Surg Oncol 2003; 10:72–9CrossRef Miner TJ, Jaques DP, Paty PB, Guillem JG, Wong WD. Symptom control in patients with locally recurrent rectal cancer. Ann Surg Oncol 2003; 10:72–9CrossRef
11.
Zurück zum Zitat Welch JP, Donaldson GA. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1979; 189:496–502CrossRef Welch JP, Donaldson GA. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1979; 189:496–502CrossRef
12.
Zurück zum Zitat Bozetti F, Bertario L, Rossetti C, et al. Surgical treatment of locally recurrent rectal carcinoma. Dis Colon Rectum 1997; 40:1421–4CrossRef Bozetti F, Bertario L, Rossetti C, et al. Surgical treatment of locally recurrent rectal carcinoma. Dis Colon Rectum 1997; 40:1421–4CrossRef
13.
Zurück zum Zitat Wanebo HJ, Koness RJ, Vezeridis MP, Cohen SI, Wrobleski DE. Pelvic resection of recurrent rectal cancer. Ann Surg 1994; 220:586–97CrossRef Wanebo HJ, Koness RJ, Vezeridis MP, Cohen SI, Wrobleski DE. Pelvic resection of recurrent rectal cancer. Ann Surg 1994; 220:586–97CrossRef
14.
Zurück zum Zitat Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003; 237:502–8PubMedPubMedCentral Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003; 237:502–8PubMedPubMedCentral
15.
Zurück zum Zitat Cunningham JD, Enker W, Cohen A. Salvage therapy for pelvic recurrence following curative rectal cancer resection. Dis Colon Rectum 1997; 40:393–400CrossRef Cunningham JD, Enker W, Cohen A. Salvage therapy for pelvic recurrence following curative rectal cancer resection. Dis Colon Rectum 1997; 40:393–400CrossRef
16.
Zurück zum Zitat Shoup M, Guillem JG, Alektiar KM, et al. Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 2002; 45:585–92CrossRef Shoup M, Guillem JG, Alektiar KM, et al. Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 2002; 45:585–92CrossRef
17.
Zurück zum Zitat Law WL, Chu KW. Resection of local recurrence of rectal cancer: results. World J Surg 2000; 24:486–90CrossRef Law WL, Chu KW. Resection of local recurrence of rectal cancer: results. World J Surg 2000; 24:486–90CrossRef
18.
Zurück zum Zitat Kakuda JT, Lamont JP, Chu DZJ, Paz IB. The role of pelvic exenteration in the management of recurrent rectal cancer. Am J Surg 2003; 186:660–4CrossRef Kakuda JT, Lamont JP, Chu DZJ, Paz IB. The role of pelvic exenteration in the management of recurrent rectal cancer. Am J Surg 2003; 186:660–4CrossRef
19.
Zurück zum Zitat Ogunbiyi OA, McKenna K, Birnbaum EH, Fleshman JW, Kodner IJ. Aggressive surgical management of recurrent rectal cancer—is it worthwhile. Dis Colon Rectum 1997; 40:150–5CrossRef Ogunbiyi OA, McKenna K, Birnbaum EH, Fleshman JW, Kodner IJ. Aggressive surgical management of recurrent rectal cancer—is it worthwhile. Dis Colon Rectum 1997; 40:150–5CrossRef
20.
Zurück zum Zitat Salo JC, Paty PB, Guillem J, Minsky BD, Harrison LB, Cohen AM. Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol 1999; 6:171–7CrossRef Salo JC, Paty PB, Guillem J, Minsky BD, Harrison LB, Cohen AM. Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol 1999; 6:171–7CrossRef
21.
Zurück zum Zitat Suzuki K, Dozois R, Devine RM, et al. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 1996; 39:730–6CrossRef Suzuki K, Dozois R, Devine RM, et al. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 1996; 39:730–6CrossRef
22.
Zurück zum Zitat Hashiguchi Y, Sekine T, Sakamoto H, et al. Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum 1999; 42:886–95CrossRef Hashiguchi Y, Sekine T, Sakamoto H, et al. Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum 1999; 42:886–95CrossRef
23.
Zurück zum Zitat Yamada K, IshizawaT, Niwa K, Chuman Y, Akiba S, Aikou T. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 2001; 88:988–93CrossRef Yamada K, IshizawaT, Niwa K, Chuman Y, Akiba S, Aikou T. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 2001; 88:988–93CrossRef
24.
Zurück zum Zitat Saito N, Koda K, Takiguchi N, et al. Curative surgery for local pelvic recurrence of rectal cancer. Dig Surg 2003; 20:192–200CrossRef Saito N, Koda K, Takiguchi N, et al. Curative surgery for local pelvic recurrence of rectal cancer. Dig Surg 2003; 20:192–200CrossRef
25.
Zurück zum Zitat Gagliardi G, Hawley PR, Hershman MJ, Arnott SJ. Prognostic factors in surgery for local recurrence of rectal cancer. Br J Surg 1995; 82:1401–5CrossRef Gagliardi G, Hawley PR, Hershman MJ, Arnott SJ. Prognostic factors in surgery for local recurrence of rectal cancer. Br J Surg 1995; 82:1401–5CrossRef
26.
Zurück zum Zitat Delpero JR, Pol B, Le Treut YP, et al. Surgical resection of locally recurrent colorectal adenocarcinoma. Br J Surg 1998; 85:372–6CrossRef Delpero JR, Pol B, Le Treut YP, et al. Surgical resection of locally recurrent colorectal adenocarcinoma. Br J Surg 1998; 85:372–6CrossRef
27.
Zurück zum Zitat Hugier M, Houry S, Barrier A. Local recurrence of cancer of the rectum. Am J Surg 2001; 182:437–9CrossRef Hugier M, Houry S, Barrier A. Local recurrence of cancer of the rectum. Am J Surg 2001; 182:437–9CrossRef
28.
Zurück zum Zitat Lopez-Kostner F, Fazio VW, Vignali A, Rybicki LA, Lavery IC. Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 2001; 44:173–8CrossRef Lopez-Kostner F, Fazio VW, Vignali A, Rybicki LA, Lavery IC. Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 2001; 44:173–8CrossRef
29.
Zurück zum Zitat Maetani S, Onodera H, Nishikawa T, et al. Significance of local recurrence of rectal cancer as a local or disseminated disease. Br J Surg 1998; 85:521–5CrossRef Maetani S, Onodera H, Nishikawa T, et al. Significance of local recurrence of rectal cancer as a local or disseminated disease. Br J Surg 1998; 85:521–5CrossRef
30.
Zurück zum Zitat Cheng C, Rodriquez-Bigas MA, Petrelli N. Is there a role for curative surgery for pelvic recurrence from rectal carcinoma in the presence of hydronephrosis? Am J Surg 2001; 182:274–7CrossRef Cheng C, Rodriquez-Bigas MA, Petrelli N. Is there a role for curative surgery for pelvic recurrence from rectal carcinoma in the presence of hydronephrosis? Am J Surg 2001; 182:274–7CrossRef
31.
Zurück zum Zitat Hoffman JP, Riley L, Carp NZ, Litwin S. Isolated locally recurrent rectal cancer: a review of incidence, presentation, and management. Semin Oncol 1993; 20:506–19PubMed Hoffman JP, Riley L, Carp NZ, Litwin S. Isolated locally recurrent rectal cancer: a review of incidence, presentation, and management. Semin Oncol 1993; 20:506–19PubMed
32.
Zurück zum Zitat Hoffman JP, Lanciano R, Carp NZ, et al. Morbidity after intraperitoneal insertion of saline-filled tissue expanders for small bowel exclusion from radiotherapy treatment fields:a prospective four year experience with 34 patients. Am Surg 1994; 60:473–82PubMed Hoffman JP, Lanciano R, Carp NZ, et al. Morbidity after intraperitoneal insertion of saline-filled tissue expanders for small bowel exclusion from radiotherapy treatment fields:a prospective four year experience with 34 patients. Am Surg 1994; 60:473–82PubMed
33.
Zurück zum Zitat Hoffman JP, Sigurdson ER, Eisenberg BL. Use of saline-filled tissue expanders to protect the small bowel from radiation. Oncology 1998; 12:51–4PubMed Hoffman JP, Sigurdson ER, Eisenberg BL. Use of saline-filled tissue expanders to protect the small bowel from radiation. Oncology 1998; 12:51–4PubMed
34.
Zurück zum Zitat Staib L, Schirrmeister H, Reske SN, Beger HG. Is 18 F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg 2000; 180:1–5CrossRef Staib L, Schirrmeister H, Reske SN, Beger HG. Is 18 F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg 2000; 180:1–5CrossRef
35.
Zurück zum Zitat Henry LR, Sigurdson E, Ross E, Hoffman JP. Hydronephrosis does not preclude curative resections of pelvic recurrences after colorectal surgery. Ann Surg Oncol 2005 (in press) Henry LR, Sigurdson E, Ross E, Hoffman JP. Hydronephrosis does not preclude curative resections of pelvic recurrences after colorectal surgery. Ann Surg Oncol 2005 (in press)
Metadaten
Titel
Resection of Isolated Pelvic Recurrences After Colorectal Surgery: Long-Term Results and Predictors of Improved Clinical Outcome
verfasst von
Leonard R. Henry, MD
Elin Sigurdson, MD, PhD
Eric A. Ross, PhD
John S. Lee, MD
James C. Watson, MD
Jonathan D. Cheng, MD
Gary M. Freedman, MD
Andre Konski, MD
John P. Hoffman, MD
Publikationsdatum
01.03.2007
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 3/2007
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9266-7

Weitere Artikel der Ausgabe 3/2007

Annals of Surgical Oncology 3/2007 Zur Ausgabe

Controversies in Oncology

Pro: SLNB in DCIS

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.